Protein Summary
May play a role in lipid exchange and transport throughout the body. May participate in reverse cholesterol transport from peripheral cells to the liver. This gene encodes a secreted high density lipoprotein which binds to apolipoprotein A-I. Apolipoprotein A-I is a relatively abundant plasma protein and is the major apoprotein of HDL. It is involved in the formation of most cholesteryl esters in plasma and also promotes efflux of cholesterol from cells. This apolipoprotein L family member may play a role in lipid exchange and transport throughout the body, as well as in reverse cholesterol transport from peripheral cells to the liver. Several different transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008]
- ENST00000319136
- ENSP00000317674
- ENSG00000100342
- ENST00000397278
- ENSP00000380448
- ENST00000397279
- ENSP00000380449
- ENST00000422706
- ENSP00000411507
- ENST00000426053
- ENSP00000388477
- APOL
- APOL
- APO-L
- FSGS4
- APOL-I
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
|---|---|---|---|
virus perturbation | 0.76 | ||
tissue sample | 0.75 | ||
cell type or tissue | 0.73 | ||
molecular function | 0.63 | ||
tissue | 0.52 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 875.07 (req: < 5)
Gene RIFs: 286 (req: <= 3)
Antibodies: 381 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 875.07 (req: >= 5)
Gene RIFs: 286 (req: > 3)
Antibodies: 381 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 12
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0